Skip to main content
$16.83 -$0.12 (-0.7%)

10:22 AM EDT on 08/14/20

Zynex, Inc. (NASDAQ:ZYXI)

CAPS Rating: 3 out of 5

Current Price $16.83 Mkt Cap $626.4M
Open $17.11 P/E Ratio 50.92
Prev. Close $16.95 Div. (Yield) $0.00 (0.0%)
Daily Range $16.60 - $17.23 Volume 108,622
52-Wk Range $7.51 - $29.73 Avg. Daily Vol. 1,225,576

Caps

How do you think NASDAQ:ZYXI will perform against the market?

Add Stock to CAPS Watchlist

All Players

58 Outperform
15 Underperform
 

All-Star Players

12 Outperform
8 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:ZYXI Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Margaritarius (41.89)
Submitted August 10, 2020

Speculative Pick: 2% allocation limit would be wise.Zynex makes FDA-approved therapy devices for pain relief and other therapeutic benefits. NexWave, their lead product, is very versatile, highly portable, and cost effective. Like most of their… More

En0chRoot (< 20)
Submitted August 16, 2008

ZYNEX INCSIC: 3845 - ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUSState location: CO | State of Inc.: NV | Fiscal Year End: 1231formerly: ARIZONA VENTURES INC (filings through 2003-08-19)formerly: CHINA GLOBAL DEVELOPMENT INC (filings through… More

Recent Community Commentary

Read the most recent pitches from players about ZYXI.

Recs

0
Member Avatar cutchemist42 (83.66) Submitted: 8/11/2020 8:24:25 PM : Outperform Start Price: $18.15 NASDAQ:ZYXI Score: -6.83

Brian feroldi...a bit speculative.

Recs

1
Member Avatar Margaritarius (41.89) Submitted: 8/10/2020 4:35:34 PM : Outperform Start Price: $18.03 NASDAQ:ZYXI Score: -5.78

Speculative Pick: 2% allocation limit would be wise.

Zynex makes FDA-approved therapy devices for pain relief and other therapeutic benefits. NexWave, their lead product, is very versatile, highly portable, and cost effective. Like most of their prescription products, they are covered by most insurance policies. In cases where insurance will not cover the cost of the unit, the CEO insists on offering the device at reduced cost directly to the patient.

The company has enjoyed a recent surge in revenue due to their newly expanded, and accelerating sales force. I personally see this as a positive - the more doctors and therapists learn about these devices, the more they buy. Revenue has grown an average of 32.5% over the past five years, 63.6% for the last twelve months. They've also bested the industry with a 79% gross profit margin over the past 12 months. With great products covered by insurance, FDA approval, reasonable prices, accelerating growth, and tiny debt (0.86% of total capital), I'm betting on this company for the long haul.

Recs

0
Member Avatar dmlong (30.14) Submitted: 7/22/2020 2:35:49 PM : Outperform Start Price: $21.67 NASDAQ:ZYXI Score: -24.76

Brian Feroldi

Leaderboard

Find the members with the highest scoring picks in ZYXI.

Score Leader

Borisincincy

Borisincincy (< 20) Score: +238.74

"Imagination is everything. It is the preview of life"s coming attractions." Albert Einstein

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
Borisincincy < 20 8/13/2008 Outperform 1Y $3.33 +409.77% +171.03% +238.74 2 Comments
AllCapSurfer 72.07 8/19/2008 Outperform 1Y $3.39 +400.30% +173.29% +227.00 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. hunger4r 91.75 7/18/2019 Outperform 5Y $7.39 +129.36% +13.12% +116.24 0 Comment
stereotyp72 72.36 1/3/2020 Outperform 5Y $8.10 +109.26% +4.08% +105.18 0 Comment
soth12 60.51 7/26/2019 Outperform 5Y $8.16 +107.72% +11.78% +95.94 0 Comment
enricozug 23.27 12/19/2019 Outperform 5Y $9.40 +80.32% +5.12% +75.20 0 Comment
Blondie442 80.12 9/6/2019 Outperform 5Y $9.24 +83.44% +12.74% +70.70 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. Faizel70 < 20 12/5/2019 Outperform 5Y $10.82 +56.65% +7.67% +48.98 0 Comment
chammond55 98.72 5/5/2020 Underperform 5Y $19.77 -14.26% +16.81% +31.07 0 Comment
LifeDaddy < 20 3/24/2020 Outperform 5Y $10.59 +60.04% +39.88% +20.17 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ZYXI.